drugset / Trial / NCT01086839

Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis

NCT01086839 ↗

Completed 69 enrolled University of Jena
RandomizedCrossoverQuadruple-blindTreatment

Summary

Rhinosinusitis disorders are almost regularly associated to Cystic Fibrosis (CF). The basic defect in CF is a dysfunction of chloride channels in exocrine glands which equally concerns upper airway mucosa. It leads to retention of secretions and consecutive chronic inflammation with bacterial superinfection. In CF rhinosinusitis can restrict quality of life, give cause to repeated ear, nose, and throat (ENT) surgery and accelerate disease progression by bacterial acquisition into the airways. The multicenter, randomized, double-blind, placebo-controlled, prospective clinical trial aims at the evaluation of a sino-nasal inhalation of sodium chloride 6% compared to isotonic saline with respect to ENT-related quality of life which is influenced by mucus retention and the resulting inflammation.

Timeline

Start
2010-03
Primary completion
2013-04
Completion
2013-06

Outcome

Missed primary endpoint

paper Sinonasal inhalation with NaCl 6.0% did not lead to superior results vs. NaCl 0.9% PMID 27267518 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride 6% Unknown 6 % Inhaled